by Jeremy Martin | Nov 17, 2012
Medcitynews recently published an article about potential hard times to come in life science and healthcare investing over the next six to eighteen months. Investing in cloud computing, mobile internet and big data has left life science funds pessimistic. In the...
by Jeremy Martin | Nov 13, 2012
In a recent article in In-Pharmatechnologist, Gian Mario Baccalini, chairman of European Fine Chemicals Group is advising active pharmaceutical ingredients (APIs) suppliers to join good manufacturing practice (GMP) standards under one unified global system. Baccalini...
by Jeremy Martin | Nov 12, 2012
November 22-23rd, 2012 our office will be closed for the holidays. We will hold no regular IRB Board meeting schedule on the November 22nd. Our office will resume normal review schedule the week of the 26th. If you need to talk to us about your need for an urgent...
by Jeremy Martin | Nov 7, 2012
IUPUI’s Innovation to Enterprise Showcase & Forum will be held on November 28, 2012 at IUPUI’s campus center. The Office of the Vice Chancellor for Research and the Indiana University Research and Technology Corporation will host students, faculty, and staff from...
by Jeremy Martin | Nov 4, 2012
Margaret Hamburg, FDA Commissioner released an article commenting on the recent meningitis outbreak. On September 18, 2012 it was confirmed that a patient in Tennessee had meningitis. By September 27, there had been eight more additional patients with similar...